Nurix Therapeutics (NRIX) Q4 2025 Earnings

Oct 9Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.03
-0.86
-0.69
-0.52

Details

Expected EPS
-0.817414
Actual EPS
-1.03
Surprise EPS
-0.21
Surprise Percent
-26.01%

Description

⁨Nurix Therapeutics⁩ (⁦NRIX⁩) has reported earnings of ⁦-1.03⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts